- Avadel Pharmaceuticals PLC
- Neuro3d SA
- Novexel SA
- IDM Pharma Inc.
- GlaxoSmithKline PLC
- Merck Serono SA
- Diaxonhit SA
- Genfit SA
- Nicox SA
- Neurotech USA Inc.
- Janssen Pharmaceutica NV
- Johnson & Johnson
- Eli Lilly & Co.
- AstraZeneca PLC
- Immutep SA
- Synt:em SA
- OncoGenex Pharmaceuticals Inc.
- Diatos SA
- Entomed SA
- Aptanomics SA
- Sanofi-Synthélabo closes takeover of Aventis
- Neuro3d completes €31.5mm third round
- Sanofi-Aventis spins off Novexel
- Immuno-Designed Molecules files for, withdraws €98.8mm IPO
- OSI purchases drug discovery assets from Cadus
- Serono to buy Genset
- Neuro3d licenses anti-psychotic from Janssen
- Immutep grosses €2.5mm
- Sonus Pharmaceuticals terminates Synt:em buy
- Diatos raises total of €9mm in second round
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.